(Q41635047)

5 October 2017

title

Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant (English)

1 reference

5 October 2017

0 references

Alessandra Ricciardi

1

1 reference

5 October 2017

John P Dalton

series ordinal

2

1 reference

5 October 2017

Momar Ndao

series ordinal

3

1 reference

5 October 2017

language of work or name

English

0 references

publication date

21 November 2014

1 reference

5 October 2017

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

5 October 2017

volume

33

1 reference

5 October 2017

issue

2

1 reference

5 October 2017

page(s)

346-353

1 reference

The global status of schistosomiasis and its control

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Schistosomiasis elimination: lessons from the past guide the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Transmission control for schistosomiasis - why it matters now.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Current status of vaccines for schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Trick or treat: the role of vaccines in integrated schistosomiasis control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Schistosomiasis: challenges for control, treatment and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

The genome of the blood fluke Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Cloning of diagnostic 31/32 kilodalton antigens of Schistosoma mansoni.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Primary structures of Sm31/32 diagnostic proteins of Schistosoma mansoni and their identification as proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Diagnostic significance of Schistosoma mansoni proteins Sm31 and Sm32 in human schistosomiasis in an endemic area in Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Immunity induced by the radiation-attenuated schistosome vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

A statistically defined endpoint titer determination method for immunoassays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Parameters of the attenuated schistosome vaccine evaluated in the olive baboon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Cutting edge: IPSE/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Aging and immune response in chronic human schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

7 January 2021

inferred from DOI database lookup

Diagnostic Mr31/32,000 Schistosoma mansoni proteins (Sm31/32): reaction with sera from Sudanese patients infected with S. mansoni or S. haematobium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

7 January 2021

inferred from DOI database lookup

Schistosoma Mansoni Infections in T-cell Deprived Mice, and the Ameliorating Effect of administering Homologous Chronic Infection Serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.016

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2014.11.016

1 reference

release_6ch36l66tbduxksadrhmswjxpa

5 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ch36l66tbduxksadrhmswjxpa

24 November 2022

mapped directly with Wikidata item

1 reference